Binding of PD-L1 results in decreased activation, proliferation, cytokine secretion, and cell survival of the T cells.30 Several types of cancer, including melanoma, lung, breast, and bladder cancers have been shown to express PD-L1 causing a decline in cytotoxic lymphocytes (CTLs), promoting tumor cell survival. This evidence concerns the gene CD274 and melanoma.